Literature DB >> 10700470

The origin of anti-nuclear antibodies in bcl-2 transgenic mice.

L Mandik-Nayak1, S Nayak, C Sokol, A Eaton-Bassiri, M P Madaio, A J Caton, J Erikson.   

Abstract

bcl-2 transgenic mice develop anti-double-stranded (ds) DNA antibodies similar to those present in systemic lupus erythematosus. To begin to understand where a breakdown in the regulation of autoreactive lymphocytes is occurring, we have used a bcl-2 transgene (Tg) in conjunction with an Ig Tg that allows us to identify and track anti-dsDNA B cells. Previously, we have shown that anti-dsDNA B cells are actively tolerized in BALB/c mice as manifested by their developmental arrest, follicular exclusion, increased in vivo turnover rate and lack of their antibody in the serum. The bcl-2 Tg mice increased the lifespan of anti-dsDNA B cells, but did not alter the other features of tolerance, indicating that the anergy of the anti-dsDNA B cells is independent of their reduced lifespan. Furthermore, these data suggest that the serum anti-dsDNA antibodies in bcl-2 transgenic mice are not due to a breakdown in the induction or maintenance of B cell anergy; rather they may originate from B cells that have transited through a germinal center.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10700470     DOI: 10.1093/intimm/12.3.353

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  9 in total

Review 1.  Understanding B-cell tolerance through the use of immunoglobulin transgenic models.

Authors:  Kirthi Raman Kumar; Chandra Mohan
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

2.  Increased lymphocyte apoptosis in mouse models of colitis upon ABT-737 treatment is dependent upon BIM expression.

Authors:  C Lutz; M Mozaffari; V Tosevski; M Caj; P Cippà; B L McRae; C L Graff; G Rogler; M Fried; M Hausmann
Journal:  Clin Exp Immunol       Date:  2015-05-19       Impact factor: 4.330

3.  Enforced expression of the apoptosis inhibitor Bcl-2 ablates tolerance induction in DNA-reactive B cells through a novel mechanism.

Authors:  Ying-Hua Wang; Yi Yan; Jeffrey S Rice; Bruce T Volpe; Betty Diamond
Journal:  J Autoimmun       Date:  2011-04-01       Impact factor: 7.094

4.  B cell activating factor (BAFF) and T cells cooperate to breach B cell tolerance in lupus-prone New Zealand Black (NZB) mice.

Authors:  Nan-Hua Chang; Yui-Ho Cheung; Christina Loh; Evelyn Pau; Valerie Roy; Yong-Chun Cai; Joan Wither
Journal:  PLoS One       Date:  2010-07-21       Impact factor: 3.240

5.  Irod/Ian5: an inhibitor of gamma-radiation- and okadaic acid-induced apoptosis.

Authors:  Tone Sandal; Linda Aumo; Lars Hedin; Bjørn T Gjertsen; Stein O Døskeland
Journal:  Mol Biol Cell       Date:  2003-04-17       Impact factor: 4.138

6.  Pharmacokinetics of the B-Cell Lymphoma 2 (Bcl-2) Inhibitor Venetoclax in Female Subjects with Systemic Lupus Erythematosus.

Authors:  Mukul Minocha; Jiewei Zeng; Jeroen K Medema; Ahmed A Othman
Journal:  Clin Pharmacokinet       Date:  2018-09       Impact factor: 6.447

7.  An Autochthonous Mouse Model of Myd88- and BCL2-Driven Diffuse Large B-cell Lymphoma Reveals Actionable Molecular Vulnerabilities.

Authors:  Ruth Flümann; Tim Rehkämper; Pascal Nieper; Hans Christian Reinhardt; Gero Knittel; Pauline Pfeiffer; Alessandra Holzem; Sebastian Klein; Sanil Bhatia; Moritz Kochanek; Ilmars Kisis; Benedikt W Pelzer; Heinz Ahlert; Julia Hauer; Alexandra da Palma Guerreiro; Jeremy A Ryan; Maurice Reimann; Arina Riabinska; Janica Wiederstein; Marcus Krüger; Martina Deckert; Janine Altmüller; Andreas R Klatt; Lukas P Frenzel; Laura Pasqualucci; Wendy Béguelin; Ari M Melnick; Sandrine Sander; Manuel Montesinos-Rongen; Anna Brunn; Philipp Lohneis; Reinhard Büttner; Hamid Kashkar; Arndt Borkhardt; Anthony Letai; Thorsten Persigehl; Martin Peifer; Clemens A Schmitt
Journal:  Blood Cancer Discov       Date:  2021-01

8.  Cooperation of ETV6/RUNX1 and BCL2 enhances immunoglobulin production and accelerates glomerulonephritis in transgenic mice.

Authors:  Eva Bauer; Michaela Schlederer; Ruth Scheicher; Jaqueline Horvath; Petra Aigner; Ana-Iris Schiefer; Renate Kain; Heinz Regele; Gregor Hoermann; Günter Steiner; Lukas Kenner; Veronika Sexl; Andreas Villunger; Richard Moriggl; Dagmar Stoiber
Journal:  Oncotarget       Date:  2016-03-15

9.  Loss of the proapoptotic protein, Bim, breaks B cell anergy.

Authors:  Paula M Oliver; Tibor Vass; John Kappler; Philippa Marrack
Journal:  J Exp Med       Date:  2006-03-06       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.